Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
20.61
+0.53 (2.64%)
Dec 20, 2024, 4:00 PM EST - Market closed
Instil Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | - | - | 0.14 | - |
| Gross Profit | - | - | - | - | 0.14 | - |
| Selling, General & Admin | 48.44 | 51.28 | 69.34 | 51.31 | 13.48 | 2.56 |
| Research & Development | 12.38 | 39.26 | 136.83 | 103.96 | 18.47 | 4.03 |
| Operating Expenses | 60.82 | 90.54 | 206.17 | 155.27 | 31.95 | 6.59 |
| Operating Income | -60.82 | -90.54 | -206.17 | -155.27 | -31.82 | -6.59 |
| Interest Expense | -7.97 | -5.21 | -1.88 | - | - | - |
| Interest & Investment Income | 7.83 | 8.87 | 3.66 | 0.08 | - | 0.07 |
| Other Non Operating Income (Expenses) | -0.29 | -0.58 | -0.56 | -1.28 | -3.94 | -0.01 |
| EBT Excluding Unusual Items | -61.24 | -87.46 | -204.96 | -156.46 | -35.76 | -6.52 |
| Merger & Restructuring Charges | 60.87 | -3.83 | -5.43 | - | -0.9 | - |
| Impairment of Goodwill | - | - | -5.7 | - | - | - |
| Asset Writedown | -68.18 | -68.18 | -1.93 | - | - | - |
| Other Unusual Items | 3.38 | 3.38 | 2.88 | -0.29 | -0.93 | - |
| Pretax Income | -75.17 | -156.09 | -225.25 | -156.76 | -37.59 | -6.52 |
| Income Tax Expense | - | - | -2.07 | 0.04 | 0.15 | - |
| Net Income | -75.17 | -156.09 | -223.18 | -156.79 | -37.74 | -6.52 |
| Net Income to Common | -75.17 | -156.09 | -223.18 | -156.79 | -37.74 | -6.52 |
| Shares Outstanding (Basic) | 7 | 7 | 6 | 5 | 1 | 0 |
| Shares Outstanding (Diluted) | 7 | 7 | 6 | 5 | 1 | 0 |
| Shares Change (YoY) | 0.05% | 0.44% | 22.19% | 562.55% | 62.05% | - |
| EPS (Basic) | -11.56 | -24.00 | -34.46 | -29.59 | -47.18 | -13.21 |
| EPS (Diluted) | -11.56 | -24.00 | -34.46 | -29.59 | -47.18 | -13.21 |
| Free Cash Flow | -58.58 | -102.69 | -264.75 | -179.97 | -80.43 | -5.5 |
| Free Cash Flow Per Share | -9.01 | -15.79 | -40.88 | -33.96 | -100.55 | -11.15 |
| Gross Margin | - | - | - | - | 100.00% | - |
| Operating Margin | - | - | - | - | -23055.07% | - |
| Profit Margin | - | - | - | - | -27346.38% | - |
| Free Cash Flow Margin | - | - | - | - | -58284.06% | - |
| EBITDA | -56.91 | -85.79 | -200.18 | -152.51 | -31.56 | -6.57 |
| D&A For EBITDA | 3.91 | 4.76 | 5.99 | 2.75 | 0.26 | 0.02 |
| EBIT | -60.82 | -90.54 | -206.17 | -155.27 | -31.82 | -6.59 |
Source: S&P Capital IQ. Standard template.
Financial Sources.